<table id="ID289" width="102%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3: Active Metabolite Pharmacokinetics and Antiplatelet Responses by CYP2C19 Metabolizer Status </caption>
<col width="17%"></col>
<col width="17%"></col>
<col width="17%"></col>
<col width="17%"></col>
<col width="17%"></col>
<col width="17%"></col>
<tbody>
<tr>
<td align="left" stylecode=" Lrule Botrule Toprule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Dose<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Ultrarapid<br/>(n=10)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Extensive<br/>(n=10)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Intermediate<br/>(n=10)<br/>
</td>
<td align="center" stylecode=" Rrule Botrule Toprule" valign="top">Poor<br/>(n=10)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Toprule" valign="top">C<sub>m</sub>
<sub>a</sub>
<sub>x</sub>
<sub> </sub>(ng/mL)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">300 mg (24 h)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">24 (10)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">32 (21)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">23 (11)<br/>
</td>
<td align="center" stylecode=" Rrule Toprule" valign="top">11 (4)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">600 mg (24 h)<br/>
</td>
<td align="center" valign="top">36 (13)<br/>
</td>
<td align="center" valign="top">44 (27)<br/>
</td>
<td align="center" valign="top">39 (23)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">17 (6)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">75 mg (Day 5)<br/>
</td>
<td align="center" valign="top">12 (6)<br/>
</td>
<td align="center" valign="top">13 (7)<br/>
</td>
<td align="center" valign="top">12 (5)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">4 (1)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">150 mg (Day 5)<br/>
</td>
<td align="center" valign="top">16 (9)<br/>
</td>
<td align="center" valign="top">19 (5)<br/>
</td>
<td align="center" valign="top">18 (7)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">7 (2)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">IPA (%)*<br/>
</td>
<td align="center" valign="top">300 mg (24 h)<br/>
</td>
<td align="center" valign="top">40 (21)<br/>
</td>
<td align="center" valign="top">39 (28)<br/>
</td>
<td align="center" valign="top">37 (21)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">24 (26)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">600 mg (24 h)<br/>
</td>
<td align="center" valign="top">51 (28)<br/>
</td>
<td align="center" valign="top">49 (23)<br/>
</td>
<td align="center" valign="top">56 (22)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">32 (25)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">75 mg (Day 5)<br/>
</td>
<td align="center" valign="top">56 (13)<br/>
</td>
<td align="center" valign="top">58 (19)<br/>
</td>
<td align="center" valign="top">60 (18)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">37 (23)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">150 mg (Day5)<br/>
</td>
<td align="center" valign="top">68 (18)<br/>
</td>
<td align="center" valign="top">73 (9)<br/>
</td>
<td align="center" valign="top">74 (14)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">61 (14)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" valign="top">
<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">VASP-PRI(%)†<br/>
</td>
<td align="center" valign="top">300 mg (24 h)<br/>
</td>
<td align="center" valign="top">73 (12)<br/>
</td>
<td align="center" valign="top">68 (16)<br/>
</td>
<td align="center" valign="top">78 (12)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">91 (12)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">600 mg (24 h)<br/>
</td>
<td align="center" valign="top">51 (20)<br/>
</td>
<td align="center" valign="top">48 (20)<br/>
</td>
<td align="center" valign="top">56 (26)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">85 (14)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule" valign="top">
<br/>
</td>
<td align="center" valign="top">75 mg (Day 5)<br/>
</td>
<td align="center" valign="top">40 (9)<br/>
</td>
<td align="center" valign="top">39 (14)<br/>
</td>
<td align="center" valign="top">50 (16)<br/>
</td>
<td align="center" stylecode=" Rrule" valign="top">83 (13)<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Lrule Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">150 mg (Day 5)<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">20 (10)<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">24 (10)<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">29 (11)<br/>
</td>
<td align="center" stylecode=" Rrule Botrule" valign="top">61 (18)<br/>
</td>
</tr>
<tr>
<td align="left" colspan="6" stylecode=" Lrule Rrule Botrule Toprule" valign="top">Values are mean (SD) <br/>* Inhibition of platelet aggregation with 5 mcM ADP; larger value indicates greater platelet inhibition <br/>† Vasodilator-stimulated phosphoprotein - platelet reactivity index; smaller value indicates greater platelet inhibition<br/>
</td>
</tr>
</tbody>
</table>